Fabrazyme 35 MG vials
Ended Awarded
- Contract number
- SPE2DB25FY22P
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,867
Award facts
- Contract value 100% obligated
- $12,867.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency valued at $12,867.46 for the supply of Fabrazyme 35 mg vials. The delivery order, awarded on August 6, 2025, with an ultimate completion date of August 27, 2025, carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities nationwide.
Fabrazyme is a specialized enzyme replacement therapy medication, indicating this delivery order supports the Defense Logistics Agency's pharmaceutical supply chain for Department of Defense healthcare sites. DMS Pharmaceutical Group has established itself as a critical supplier to federal healthcare systems, leveraging its woman-owned small business status to compete effectively in federal procurement markets. The company's contract portfolio demonstrates consistent success in delivering branded and generic prescription drugs, biologics, and specialized pharmaceutical products to military medical facilities, positioning it as a key distributor within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FY22P?
SPE2DB25FY22P was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FY22P worth?
The government has obligated $12,867 on SPE2DB25FY22P.
Is contract SPE2DB25FY22P an order under another contract?
Yes. SPE2DB25FY22P is a delivery order under SPE2DB22D9362, an indefinite delivery contract.
Was contract SPE2DB25FY22P competed?
The extent of competition for SPE2DB25FY22P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award